Scholars Central

EditorialPublished 29 May 2021

Linezolid

Authors: Giovanni Tosi

Pharmaceutica Analytica Acta

Volume 12 · Issue 5 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Linezolid is an anti-infection utilized for the treatment of diseases brought about by Gram-positive microbes that are impervious to different anti-infection agents. Linezolid is dynamic against most Gram-positive microbes that cause infection, including streptococci, vancomycin-safe enterococci (VRE), and methicillin-safe Staphylococcus aureus (MRSA). The principle utilizes are diseases of the skin and pneumonia in spite of the fact that it very well might be utilized for an assortment of different contaminations including drug-safe tuberculosis. It is utilized either by infusion into a vein or by mouth. At the point when given for brief periods, linezolid is a generally protected anti-infection.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutica Analytica Acta.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Giovanni Tosi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels